aripiprazole 2 mg
1 INDICATIONS AND USAGE Aripiprazole tablets are indicated for the treatment of: Schizophrenia [see Clinical Studies ( 14.1 )] Irritability Associated with Autistic Disorder [see Clinical Studies ( 14.4 )] Treatment of Tourette’s Disorder [ see Clinical Studies ( 14.5 )] Additional pediatric use information is approved for Otsuka America Pharmaceutical, Inc.’s ABILIFY ® (aripiprazole) product. However, due to Otsuka America Pharmaceutical, Inc.’s marketing exclusivity rights, this drug product is not labeled with that information. Aripiprazole tablets are an atypical antipsychotic. The oral formulation is indicated for: Schizophrenia ( 14.1 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette’s disorder ( 14.5 )
apotex corp
RECTANGLE GREEN A 2
A 2 RECTANGLE GREEN
Related Pills
aripiprazole 10 mg
apotex corp
aripiprazole 2 mg
apotex corp
aripiprazole 5 mg
apotex corp
aripiprazole 5 mg
apotex corp
aripiprazole 15 mg
Apotex Corp
Oxycodone Hydrochloride Oxycodone Hydrochloride 30 MG Oral Tablet
American Health Packaging
Oxycodone Hydrochloride Oxycodone Hydrochloride 30 MG Oral Tablet
American Health Packaging
Sucralfate 1 g
Teva Pharmaceuticals USA Inc
Sucralfate 1 g
Teva Pharmaceuticals USA Inc
xarelto rivaroxaban tablet film coated xarelto rivaroxaban kit
janssen pharmaceuticals, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied
ARIPIPRAZOLE Tablets, USP 2 mg are available for oral administration as green, rectangular, slightly biconvex tablets, engraved "2" on one side and "A" on the other side. Bottles of 30 (NDC 60505-3075-3) Bottles of 1,000 (NDC 60505-3075-8)
ARIPIPRAZOLE Tablets, USP 5 mg are available for oral administration as blue, rectangular, slightly biconvex tablets, engraved “5” on one side and “A” on the other side. Bottles of 30 (NDC 60505-2673-3) Bottles of 1,000 (NDC 60505-2673-8)
ARIPIPRAZOLE Tablets, USP 10 mg are available for oral administration as pink, rectangular, slightly biconvex tablets, engraved “10” on one side and “A” on the other side. Bottles of 30 (NDC 60505-2674-3) Bottles of 1,000 (NDC 60505-2674-8)
ARIPIPRAZOLE Tablets, USP 15 mg are available for oral administration as yellow, round, slightly biconvex tablets, engraved “ARI” over “15” on one side and “APO” on the other side. Bottles of 30 (NDC 60505-2675-3) Bottles of 1,000 (NDC 60505-2675-8)
ARIPIPRAZOLE Tablets, USP 20 mg are available for oral administration as white to off-white, round, slightly biconvex tablets, engraved “ARI” over “20” on one side and “APO” on the other side. Bottles of 30 (NDC 60505-2676-3) Bottles of 1,000 (NDC 60505-2676-8)
ARIPIPRAZOLE Tablets, USP 30 mg are available for oral administration as pink, round, slightly biconvex tablets, engraved “ARI” over “30” on one side and “APO” on the other side. Bottles of 30 (NDC 60505-2677-3) Bottles of 1,000 (NDC 60505-2677-8) 16.2 Storage Tablets Store at 20ºC to 25ºC (68ºF to 77ºF); excursions permitted from 15ºC to 30ºC (59ºF to 86ºF) [see USP Controlled Room Temperature].
More pills like RECTANGLE A 2